<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04251338</url>
  </required_header>
  <id_info>
    <org_study_id>S62961</org_study_id>
    <nct_id>NCT04251338</nct_id>
  </id_info>
  <brief_title>Delayed Visual Maturation: Outcome and Predictive Factors</brief_title>
  <acronym>DVM</acronym>
  <official_title>Delayed Visual Maturation: Outcome and Predictive Factors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objectives of the study are to describe the developmental outcome in a population of
      children with delayed visual maturation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      description of the developmental outcome of children with delayed visual maturation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 3, 2019</start_date>
  <completion_date type="Actual">February 10, 2020</completion_date>
  <primary_completion_date type="Actual">February 10, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>delayed visual maturation.</measure>
    <time_frame>1998-2016</time_frame>
    <description>the prevalence of developmental problems in children with delayed visual maturation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Level of development</measure>
    <time_frame>1998-2016</time_frame>
    <description>by questionnaire:type of education/school , problems with writing, mathematics: yes or no</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fine and gross motor skills</measure>
    <time_frame>1998-2016</time_frame>
    <description>by questionnaire: physiotherapy needed yes or no</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ophthalmological problems</measure>
    <time_frame>1998-2016</time_frame>
    <description>by questionnaire : visual problems, wearing glasses? taped eyes?</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual acuity</measure>
    <time_frame>1998-2016</time_frame>
    <description>assested at the last consultation indicated in Snellen</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">71</enrollment>
  <condition>Delayed Visual Maturation</condition>
  <arm_group>
    <arm_group_label>delayed visual maturation</arm_group_label>
    <description>children with delayed visual maturation</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        patients seen in UZ Leuven between 1998 and 2016 with diagnosis of delayed visual
        maturation who meet the inclusion criteria.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Infants (male or female) with suboptimal/absent visual contact at the age of â‰¥3
             months, without other known general developmental delay at the time diagnosis of
             delayed visual contact and without anatomic ocular abnormalities at the initial
             ophthalmological examination.

        Exclusion Criteria:

          -  Children with known underlying psychomotor developmental delay or epilepsy at first
             ophthalmic consultation.

          -  Children with ophthalmic (anatomical) abnormalities that explain delayed visual
             maturation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Months</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ingele Casteels, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UZ Leuven</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universitaire Ziekenhuizen Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>December 31, 2019</study_first_submitted>
  <study_first_submitted_qc>January 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 31, 2020</study_first_posted>
  <last_update_submitted>May 7, 2020</last_update_submitted>
  <last_update_submitted_qc>May 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>delayed visual maturation</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

